“Attention Shareholders: Important Reminder from Pomerantz Law Firm Regarding LO Stock”

Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. New York City, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX). Investors who have purchased shares of Kyverna Therapeutics, Inc. are advised to contact Danielle Peyton…

Read More

Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services

Charmingly eccentric, full of personality, and designed for maximum reader engagement NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP is investigating claims on behalf of investors of IGM Biosciences, Inc. (“IGM” or the “Company”) (NASDAQ:IGMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. The Intriguing…

Read More